Yahoo Web Search

Search results

1. • 

     Exploring Novartis And Two More High-Yield Dividend Stocks In Switzerland

     Simply Wall St. via Yahoo Finance· 4 hours ago

     The Switzerland market recently experienced a moderate decline, influenced by investor concerns that...

2. • 

     Is Novartis AG (NYSE:NVS) Investors’ Favorite International Dividend Stock?

     Insider Monkey via Yahoo Finance· 3 days ago

     We recently compiled a list of 12 Best International Dividend Stocks to Buy Now. Since Novartis AG...

3. • Capital Research Global Investors Increases Stock Position in Novartis AG (NYSE:NVS)

     ETF DAILY NEWS· 7 days ago

     Capital Research Global Investors raised its position in shares of Novartis AG (NYSE:NVS – Free Report) by 0.0% in the 4th quarter, according to its most recent 13F filing ...

4. • 

     Radioactive drugs strike cancer with precision

     Knowable Magazine via Yahoo News· 1 day ago

     The move follows similar billion-dollar-plus transactions made in recent months by Bristol Myers Squibb (BMS) and Eli Lilly, along with earlier takeovers...

5. • 

     Study Elucidates Skin Signs of VEXAS Syndrome

     Medscape· 3 hours ago

     Skin manifestations are common in the vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic (VEXAS) syndrome and present early in the disease course....

6. • Erasca (NASDAQ:ERAS) vs. Ascendis Pharma A/S (NASDAQ:ASND) Head-To-Head Contrast

     ETF DAILY NEWS· 6 hours ago

     Erasca (NASDAQ:ERAS – Get Free Report) and Ascendis Pharma A/S (NASDAQ:ASND – Get Free Report) are both medical companies, but which is the superior investment? We will compare the two businesses ...

7. • 

     NHS and ABPI announce new guidelines ahead of UK elections

     Pharmaceutical Technology via Yahoo Finance· 14 hours ago

     Speaking on a panel discussing the guidelines, Pauline Hakutangwi, value and access marketing...

8. • 

     Why Alcon (ALC) is a Top Momentum Stock for the Long-Term

     Zacks via Yahoo Finance· 4 days ago

     From Mar 20, 2002 until its 2011-merger into Novartis, Alcon was publicly listed and traded on the...

9. • 

     Tirzepatide Shows Improvements in MASH Resolution, Fibrosis

     Medscape· 4 days ago

     Encouraging phase 2 results of tirzepatide in the resolution of MASH and improvement in fibrosis...

10. • 

      Fumihiko Maki, honored architect of understated buildings, dies at 95 - The Boston Globe

      The Boston Globe· 1 day ago

      In an interview for this obituary in 2010, Mr. Maki said his goal was not to make his buildings...